Bharat Misra, MD, Borland-Groover Clinic, Jacksonville, FL; Mayur S. Ramesh, MD, Henry Ford Health System, Detroit, MI; Mary Kay Sobcinski, RN, MHA, Rebiotix Inc, Roseville, MN Purpose Recurrent C. difficile infection is a debilitating condition known to have major effects on both patient physical and mental health. Little is known about the quality of life aspects […]
Microbiota Restoration Therapy Posters
Background Clostridium difficile infection is the leading cause of healthcare acquired diarrhea, and is linked to perturbations of the intestinal microbiota initiated by antibiotics. Approximately, 20% to 30% of patients will go on to experience recurrence, with each additional episode predisposing to further recurrence. No drug is currently indicated for recurrent Clostridium difficile infection.